Also known as: Johns Hopkins
Wafik S. El-Deiry highlighted p53 research and the August 2025 approval of dordaviprone/modeyso, the first treatment for diffuse gliomas with H3K27M mutations. Separate posts also described glioblastoma precision oncology discussions and a lifetime achievement award in Mumbai.
ARVO named Sangeetha Kandoi and Ellen Konadu Antwi-Adjei as the 2026 recipients of its annual Advocacy Awards. The honors recognize advocacy in eye and vision research and efforts to expand equitable access to care.
Sen. Josh Hawley and Rep. Diana Harshbarger introduced legislation to withdraw FDA approval of mifepristone nationwide, making distribution a federal violation and allowing patients to sue manufacturers.
Ultrasensitive testing of tumor DNA in blood and urine may identify muscle-invasive bladder cancer patients who can safely forgo radical cystectomy, with 69% achieving 3-year bladder-intact survival after systemic therapy.
U.S. regulators have received more than 1,400 reports since 2021 involving AI-enabled surgical devices, including allegations of botched surgeries and misidentified body parts. The FDA has authorized over 1,300 AI-integrated medical devices.
Drug Hunter's monthly molecule selections from July through December 2025 feature innovative small molecule candidates targeting pain, epilepsy, cancer, infectious diseases, and metabolic disorders, including non-opioid pain agents and precision therapies for rare conditions.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07603518 |
The Pharmacokinetics of a Hemp-Based Topical Product |
NOT_YET_RECRUITING | PHASE1 |
| NCT07592611 |
Deep Brain Stimulation for Treatment-Resistant Schizophrenia |
NOT_YET_RECRUITING | NA |
| NCT07569367 |
A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia Spectrum |
NOT_YET_RECRUITING | |
| NCT07565493 |
Psilocybin Administration With 5-HT1a Blockade |
NOT_YET_RECRUITING | EARLY_PHASE1 |
| NCT07556107 |
The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS) |
NOT_YET_RECRUITING | PHASE4 |
| NCT07553325 |
Risk-informed Shared-decision Making Engagement Strategy for Patients With Prediabetes |
NOT_YET_RECRUITING | NA |
| NCT07553312 |
Clinic-Community Bridge to Improve Health Outcomes for Abused Women Living With HIV/AIDS |
ENROLLING_BY_INVITATION | |
| NCT07541131 |
Lower Intersecting HIV-related Stigmas to Facilitate Treatment as Prevention (LIFT) |
ENROLLING_BY_INVITATION | NA |
| NCT07540000 |
The INTERvening for LUNG Health Trial |
NOT_YET_RECRUITING | PHASE4 |
| NCT07532252 |
Daridorexant for Alcohol Use Disorder |
NOT_YET_RECRUITING | PHASE2 |
